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The HECT-domain ubiquitin ligase Huwe1 controls 
neural differentiation and proliferation by destabilizing 
the N-Myc oncoprotein
Xudong Zhao1,7, Julian Ik-Tsen Heng5, Daniele Guardavaccaro6, Richeng Jiang1, Michele Pagano6, Francois 
Guillemot5, Antonio Iavarone1,2,3,8 and Anna Lasorella1,2,4,8
Development of the nervous system requires that timely withdrawal from the cell cycle be coupled with initiation of 
differentiation. Ubiquitin-mediated degradation of the N-Myc oncoprotein in neural stem/progenitor cells is thought to trigger 
the arrest of proliferation and begin differentiation. Here we report that the HECT-domain ubiquitin ligase Huwe1 ubiquitinates 
the N-Myc oncoprotein through Lys 48-mediated linkages and targets it for destruction by the proteasome. This process is 
physiologically implemented by embryonic stem (ES) cells differentiating along the neuronal lineage and in the mouse brain 
during development. Genetic and RNA interference-mediated inactivation of the Huwe1 gene impedes N-Myc degradation, 
prevents exit from the cell cycle by opposing the expression of Cdk inhibitors and blocks differentiation through persistent 
inhibition of early and late markers of neuronal differentiation. Silencing of N-myc in cells lacking Huwe1 restores neural 
differentiation of ES cells and rescues cell-cycle exit and differentiation of the mouse cortex, demonstrating that Huwe1 restrains 
proliferation and enables neuronal differentiation by mediating the degradation of N-Myc. These findings indicate that Huwe1 
links destruction of N-Myc to the quiescent state that complements differentiation in the neural tissue.
N-Myc, a member of the Myc family of transcription factors that includes 
c-Myc and L-Myc, is normally expressed in the developing nervous 
system and other selected tissues1,2. Under normal conditions, N-Myc 
expression predominates in neural stem cells and neuroectodermal pro-
genitors where c-Myc is undetectable1. Recent results from mice carry-
ing targeted deletion of the N-myc gene in these cellular compartments 
established that N-myc expression in the developing nervous system is 
essential for the correct timing of cell-cycle exit and differentiation. In 
the absence of N-myc, precocious differentiation and premature with-
drawal from the cell cycle of neural stem cells and cortical progenitors is 
associated with upregulation of Cdk inhibitors and reduced expression 
of the Myc target gene cyclin D2 (ref. 3).
One of the most important mechanisms by which N-Myc is regu-
lated is at the level of protein stability, the turnover being accelerated 
by differentiation-promoting signals but significantly reduced in stem 
cells and cycling neural progenitors4–6. It has long been recognized that 
N-Myc is a short-lived protein targeted for ubiquitin-mediated degra-
dation by the proteasome7–10. When linked through Lys 48 of ubiquitin, 
polyubiquitin chains function as signals for recognition by the protea-
some that cleaves the ubiquitinated substrate. The accuracy of the system 
is conferred by the E3 ubiquitin ligase, which retains high specificity for 
the substrate11,12.
Here we identify the HECT-domain ubiquitin ligase Huwe1 as the 
destabilizing enzyme that targets N-Myc for proteasomal-mediated deg-
radation in the neural tissue. This event is necessary for differentiation 
and cell-cycle withdrawal of stem cells and neural progenitors in vitro 
and in vivo.
RESULTS
Identification of Huwe1 as a partner of N-Myc in neural cells
To identify the natural protein partners of N-Myc in neural cells, we 
expressed a Flag–HA epitope-tagged N-Myc (FH–N-Myc) in the human 
neuroblastoma cell line IMR32. We analysed proteins that co-purify with 
FH–N-Myc by LC/MS/MS after sequential Flag–HA immunoprecipita-
tion and peptide elution13 and discovered that N-Myc complexes contain 
Huwe1 (Fig. 1a). Huwe1 (also known as Ureb1, Lasu1, Mule, ARF–BP1 
or HECTH9) is a recently identified ubiquitin ligase, which belongs to 
the HECT (homologue of E6AP) family of E3 enzymes and is thought to 
target the ubiquitination and consequent degradation of Mcl1 and p53 
(refs 14, 15). Huwe1 has also been reported to ligate c-Myc to a ubiquitin 
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chain that may not target c-Myc for degradation by the proteasome16. 
N-Myc and Huwe1 interacted physically in independent immunopre-
cipitation experiments of Flag–N-Myc followed by western blotting for 
Huwe1, in which the protein was detected by two different affinity-puri-
fied rabbit polyclonal antibodies (Supplementary Information, Fig. S1a 
and data not shown). We also showed that endogenous N-Myc binds to 
endogenous Huwe1 in IMR32 neuroblastoma cells (Fig. 1b). Using puri-
fied GST–N-Myc in a pull-down assay, we confirmed that N-Myc interacts 
specifically with Huwe1 in vitro (Fig. 1c). Next, we compared the affinity 
of the interaction between N-Myc or c-Myc and Huwe1. By quantitative 
analysis of Huwe1–N-Myc and Huwe1–c-Myc complexes in U2OS cells 
engineered to express exogenous N-Myc, we found that a 4-fold higher 
fraction of N-Myc than c-Myc was bound to Huwe1 in the cells (Fig. 1d). 
To determine whether Huwe1 affects the steady-state levels of N-Myc, we 
elevated or decreased Huwe1 in IMR32 and observed the effects, if any, on 
the accumulation of N-Myc. Expression of either full-length Huwe1 or an 
amino-terminal Huwe1 deletion mutant that retains the WWE, UBE and 
HECT domains (Huwe1–C) caused a marked reduction in the steady-
state levels of endogenous N-Myc (Fig. 1e; Supplementary Information, 
Fig. S1b). However, expression of the N-terminal Huwe1 fragment 
(Huwe1–N), which lacks the key ubiquitin conjugation domain, did not 
decrease N-Myc (Supplementary Information, Fig. S1b). We also analysed 
whether, in neural cells, Huwe1 affects the accumulation of other putative 
substrates, namely p53, Mcl1 and c-Myc. Ectopic expression of Huwe1 
reduced Mcl-1, an anti-apoptotic protein, but did not affect p53 (Fig. 1e), 
whereas c-Myc is not expressed either in the IMR32 neuroblastoma cells 
nor in neuroectodermal tissues1,2. RNA interference (siRNA)-mediated 
depletion of Huwe1 in IMR32 cells caused a marked accumulation of 
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Figure 1 Huwe1 binds N-Myc in vivo and controls N-Myc stability.  
(a) Identification of Huwe1 in N-Myc complexes from human 
neuroblastoma cells. Silver staining of affinity purified FH–N-Myc 
complexes from IMR32 cells. Specific N-Myc-interacting proteins were 
identified by mass spectrometry and are indicated. (b) Lysates from 
IMR32 cells were immunoprecipitated with an anti-N-Myc antibody 
or normal mouse IgG (IgG). Western blotting was performed using 
anti-Huwe1, anti-Max and anti-N-Myc antibodies. α-tubulin is shown 
as a negative control for binding. Input is 1/100th of total extracts. 
(c) Lysates from IMR32 cells were mixed with GST or GST–N-Myc 
fusion proteins. Bound proteins were analysed by western blotting 
for Huwe1 or cdc27. Input is 1/50. Molecular markers are indicated 
on the left. (d) Lysates of U2OS cells stably expressing N-Myc were 
immunoprecipitated with antibodies directed against Huwe1 or rabbit 
IgG (IgG). Immunoprecipitates were resolved on SDS–PAGE and analysed 
by western blotting using the indicated antibodies. Input is 1/250. 
The percentage of cellular N-Myc and c-Myc associated with Huwe1 is 
indicated. (e) IMR32 cells were transfected with plasmids expressing 
the V5-tagged full-length Huwe1 or the empty vector. The levels of 
endogenous N-Myc, p53 and Mcl-1 were examined by immunoblotting. 
The V5 antibody was used to detect exogenously expressed Huwe1. (f) 
IMR32 cells were transfected with control (siCTR) or Huwe1 (siHuwe1) 
siRNA. Lysates were analysed by immunoblotting for the indicated 
proteins. (g) Parallel samples were analysed for gene expression by semi-
quantitative RT–PCR. (h) IMR32 cells were transfected with control 
(siCTR) or Huwe1 (siHuwe1) siRNA and treated with cycloheximide (CHX) 
for the indicated times. α-tubulin is shown as a control for loading. Full 
scans of immunoblots are shown in Supplementary Information, Fig. S9.
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N-Myc and its targets Id2 (refs 17–20) and cyclin E1 (refs 21–23) without 
detectable changes in N-myc mRNA levels (Fig. 1f, g). Neither LRP130 
protein (another N-Myc interactor) nor p53 were affected (Fig. 1f). Using 
cycloheximide, an inhibitor of protein synthesis, we determined the half-
life of N-Myc after Huwe1 silencing. Compared with controls, cells treated 
with Huwe1 siRNA showed stabilization of the N-Myc protein half-life 
(Fig. 1h).
Huwe1 ubiquitinates N-Myc and primes it for proteasomal-
mediated degradation
To determine whether Huwe1 is directly responsible for polyubiquitina-
tion of N-Myc, we purified a recombinant full-length Huwe1 protein 
produced from a baculovirus-based expression system (Supplementary 
Information, Fig. S1c). In the presence of E1, E2 (UbcH5) and an ATP-
regenerating system, purified recombinant Huwe1 attached polyubiquitin 
chains to 35S-labelled, in vitro translated N-Myc in a concentration- and 
time-dependent manner (Fig. 2a, b, top panel). Mutation of the critical 
Cys 4341 to Ala in the HECT domain of Huwe1 (Huwe1–CA) eliminated 
all ubiquitin ligase activity towards N-Myc (Fig. 2a). Interestingly, we 
found that although c-Myc is ubiquitinated by Huwe1 in this in vitro 
assay, the efficiency of ubiquitin chain-linkage on c-Myc by Huwe1 
was noticeably lower than on N-Myc (Fig. 2b, lower panel). This find-
ing indicates that N-Myc is a better substrate of Huwe1 than c-Myc. 
Next, we determined the mechanism by which Huwe1 links ubiquitin 
to N-Myc. We performed the in vitro ubiquitination reaction for N-Myc 
using purified Huwe1 and wild-type ubiquitin or ubiquitin molecules 
carrying point mutations in Lys 48 or Lys 63, two well established sites 
of isopeptide linkage (K48R, K63R, or K48R;K63R). When K48R ubiq-
uitin was added to the in vitro reaction, the abundance of the slowest 
migrating bands decreased. This effect is due to capping of polyubiquitin 
chains by the mutant ubiquitin. In fact, K48R ubiquitin competes with 
the ubiquitin present in the wheatgerm lysate (used to translate N-Myc in 
vitro) and terminates the polyubiquitin chains. Although the K48R;K63R 
mutant produced the same effect, addition of K63R ubiquitin had no 
effect on the formation of polyubiquitin chains (Fig. 2c). Moreover, we 
compared the mechanism underlying ubiquitin linkage of N-Myc and 
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Figure 2 Huwe1 ubiquitinates and directs N-Myc degradation by the 
proteasome. (a) In vitro-translated, 35S-labelled N-Myc was incubated with 
increasing concentrations of wild-type Huwe1 (WT) or Huwe1–CA (CA) 
in the absence or presence of ubiquitin and the E2 protein UbcH5, as 
indicated, for 60 min at 37 °C. (b) In vitro-translated, 35S-labelled-N-Myc 
(upper panel) or c-Myc (lower panel) were incubated in the presence or in 
the absence of Huwe1 for the indicated times and the abundance of 35S-
labelled Myc proteins was detected by fluorography. (c) Huwe1 catalyses 
the assembly of Lys 48-linked polyubiquitin chains on N-Myc in vitro. 
Ubiquitination of N-Myc by Huwe1 was carried out in the presence of either 
wild-type ubiquitin or the indicated ubiquitin mutants for 60 min at 37 °C. 
35S-labelled N-Myc was detected by fluorography. (d) In vivo ubiquitination 
of Myc proteins by Huwe1. U2OS cells stably transfected with the retroviral 
expression plasmid pLZRS–N-Myc were cotransfected with empty vector 
or V5–Huwe1 and wild-type HA–ubiquitin (WT) or the mutants Lys 48 only 
(K48O) or Lys 63 only (K63O). After treatment with MG132 (5 µM) for 
3 h, lysates were prepared in denaturing buffer and identical aliquots were 
immunoprecipitated with antibodies directed against N-Myc (left panel) 
or c-Myc (right panel). An anti-HA antibody was used to detect ubiquitin 
conjugates. Note that the efficiency of K48O-mediated ubiquitination 
is underestimated, compared with ubiquitination by WT ubiquitin, as a 
consequence of reduced expression of V5-Huwe1. (e) Total extracts from the 
experiment in d were analysed by immunoblotting with an anti-HA antibody 
to detect ubiquitin monomers and an anti-V5 antibody to detect V5-tagged 
Huwe1 full-length. β-actin is a control for loading. (f) Ubiquitination 
of N-Myc by Huwe1 was carried out in the absence or presence of 26S 
proteasome particles, for the indicated times at 37 °C. 35S-labelled N-Myc 
was detected by fluorography of SDS–PAGE electrophoresed reactions. The 
bracket marks bands corresponding to polyubiquitinated N-Myc. Full scans 
of immunoblots are shown in Supplementary Information, Fig. S9.
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c-Myc by Huwe1 in vivo. These assays were performed in U2OS cells 
expressing N-Myc and c-Myc. They demonstrated that ectopic expres-
sion of Huwe1 led to polyubiquitin linkage of either N-Myc or c-Myc 
through HA–ubiquitin wild-type and mutant in all Lys except Lys 48 
(K48O) but not Lys 63 (K63O) (Fig. 2d, e). Together, these data indicate 
that the polyubiquitin chains attached by Huwe1 on N-Myc are linked 
through Lys 48, consistent with the recently established notion that 
HECT-domain ubiquitin ligases form homogeneous but not heteroge-
neous Lys chains24. In agreement with the role of Lys 48-linked ubiquitin 
chains as preferred recognition targets by the 26S proteasome25,26, we 
found that addition of purified 26S proteasome particles to the ubiqui-
tination reaction mixture caused degradation of the polyubiquitinated 
N-Myc species (Fig. 2f).
The Huwe1–N-Myc pathway controls neural differentiation of 
mouse ES cells
The expression of N-myc is highly enriched in mouse ES cells and must 
be downregulated to achieve neuronal differentiation and enable the 
post-mitotic state27–29. To determine whether Huwe1 is implicated in this 
process, we first used gene trapping for constitutive genetic inactivation 
of the Huwe1 locus in mouse ES cells. The RRE249 and HMA095 ES 
clones have been derived from the parental E14Tg2a.IV cells by inser-
tion of the gene-trap vector containing β-geo into introns 4 and 74 of the 
Huwe1 gene, respectively (Supplementary Information, Fig. S2). Genomic 
PCR followed by DNA sequencing, as well as RT–PCR and western blot 
experiments from the two ES clones, confirmed that both insertions abol-
ish the splicing of the Huwe1 exons that code for the essential HECT 
domain (Supplementary Information, Fig. S2b, c and data not shown). 
Functional analysis of the Huwe1–N-Myc pathway in RRE249 ES cells 
is shown in Figs 3–4; similar results have been obtained in the HMA095 
clone. The leukaemia inhibitory factor (LIF) is essential for maintaining 
mouse ES cells in a self-renewing and undifferentiated state that closely 
resembles the pluripotent cells of the inner cell mass30. Following LIF 
withdrawal, ES cells rapidly lose their self-renewal and pluripotent capac-
ity, undergo differentiation along multiple lineages, enter a quiescent state 
and eliminate N-Myc. Removal of LIF caused a clear increase in Huwe1 
expression and  elevation in the level of the Cdk inhibitor p27Kip1, a cell-
cycle regulator whose expression in neural progenitors requires collapse 
of N-Myc3,31. Remarkably, LIF removal from Huwe1-null ES cells failed 
to cause downregulation of N-Myc and upregulation of p27Kip1 (Fig. 3a). 
In Huwe1-null cells we observed only minimal elevation of c-Myc 
(Figs 3a, 4a). Huwe1 mRNA levels remained unchanged throughout 
the course of the experiment, whereas that of N-myc and c-myc mRNA 
gradually decreased in a manner that was indistinguishable in wild-type 
and Huwe1-null ES cells (Fig. 3b). Thus, the observed protein changes in 
Huwe1-null ES cells were not secondary to changes in the corresponding 
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Figure 3 Genetic inactivation of Huwe1 impairs N-Myc degradation.  
(a) Wild-type and Huwe1-trapped ES cells were plated in the presence of LIF 
and 18 h later deprived of LIF for the indicated times. Lysates were analysed 
by immunoblotting using the indicated antibodies. (b) Parallel cultures 
were analysed for expression of Huwe1, N-myc, c-myc and β-actin by semi-
quantitative RT–PCR. (c) Quantitative real-time PCR (qRT–PCR) analysis 
of the mRNA of selected Myc target genes in wild-type and Huwe1-trapped 
ES cells. Data represent mean ± s.e.m. (n = 3; *P < 0.01 **P < 0.001 
Student’s t-test). (d) Wild-type and Huwe1-trapped ES cells were treated 
with CHX for the indicated times 24 h after LIF deprivation. Lysates were 
analysed by western blotting using anti-N-Myc and anti-c-Myc antibodies. 
β-actin is shown as a control for loading. (e) Quantification of N-Myc from 
the experiment in d. (f) Quantification of c-Myc from the experiment in d. 
Full scans of immunoblots are shown in Supplementary Information, Fig. S9.
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mRNAs. Moreover, Huwe1-null ES cells deprived of LIF showed elevated 
expression of CDC25A32 and Top1 (refs 33, 34), and decreased expres-
sion of N-cadherin35 and Serpine1 (refs 33, 36), which are induced and 
repressed Myc target genes, respectively (Fig. 3c). Consistent with the 
notion that N-Myc is a more efficient substrate than c-Myc, we found 
that knockout of Huwe1 in ES cells stabilized N-Myc more efficiently 
than c-Myc (Fig. 3d–f).
The differentiation pathways induced in ES cells after LIF removal 
are heterogeneous and poorly controlled. In contrast, ES cells plated on 
gelatin-coated tissue culture dishes in a serum-free medium supporting 
neural differentiation (N2-B27) commit synchronously along the neural 
fate and undergo terminal neuronal differentiation37. Under these condi-
tions, N-Myc rapidly decreased and became undetectable 48 h after neu-
ronal induction. Complete loss of the stem-cell markers Oct3/4 occurred 
within 24–36 h and was associated with elevation of Huwe1 and p27Kip1 
(Fig. 4a). In contrast, in Huwe1 knockout cells the stability of N-Myc was 
increased, N-Myc levels were preserved, downregulation of Oct3/4 was 
delayed and p27Kip1 was not induced. Consistent with these findings, Mcl1 
and c-Myc were slightly upregulated but p53 was not increased in Huwe1-
null ES cells (Fig. 4a). Because elimination of N-Myc is required for neu-
ronal differentiation38–40, we asked whether persistent levels of N-Myc, 
caused by loss of Huwe1, impair neuronal differentiation of ES cells. 
Three early markers of neuronal differentiation (Neurogenin2 (Ngn2), 
N-cadherin (N-cad) and FGF8, ref 41–43) were induced in wild-type ES 
cells by 72 h of growth in the neural culture system but remained unde-
tectable in Huwe1-null ES cells (Fig. 4b). Failure to induce Neurogenin2, 
N-cadherin and FGF8 was associated with the absence of morphological 
signs of neuronal differentiation in Huwe1-null cultures (less than 10% of 
cells displayed neurite extension) following re-plating on poly-d-lysine in 
neural medium. In contrast, 90% of wild-type ES cells extended long neu-
rites and reached a highly organized and networked neuronal differentia-
tion (Fig. 4c). Accordingly, the expression of MAP2, a marker of mature 
neurons, was induced in wild-type ES cells but remained undetectable in 
the absence of Huwe1 (Fig. 4d). Next, we sought to determine whether 
N-Myc is the functionally critical degradation substrate of Huwe1 in ES 
cells primed to differentiate along the neuronal lineage. To do this, we 
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Figure 4 Blockade of neuronal differentiation by genetic inactivation of 
Huwe1 is rescued by silencing of N-myc. (a) Wild-type and Huwe1-trapped 
ES cells were plated in differentiation medium and collected at the indicated 
times. Lysates were analysed by immunoblotting using the indicated 
antibodies. (b) Cells treated as in a were examined for gene expression by 
semi-quantitative RT–PCR. (c) Cells cultured for 4 days in differentiation 
medium were trypsinized and re-plated in the same medium on poly-d-lysine- 
and laminin-coated dishes. Bright-field images were taken 2 (day 6) and 4 
(day 8) days after re-plating. Scale bar is 40 µm. (d) Cultures treated as in c 
were collected at the indicated times and analysed by immunoblotting using 
the neuronal marker MAP2. (e) Cells transduced with lentivirus expressing 
shRNA against N-myc or control lentivirus were analysed by western blotting 
using antibodies directed against N-Myc. β-actin is shown as a control for 
loading. (f) Cells treated as in e were plated in differentiation medium, 
collected at the indicated times and examined for gene expression by 
semi-quantitative RT–PCR (left panel). The number of cells showing axonal 
projections was scored. At least 1,500 cells were counted from 36 randomly 
chosen fields (right panel). Results are mean ± s.e.m. (*P = 4.7 × 10–8, 
Student’s t-test, n = 3). Full scans of immunoblots are shown in 
Supplementary Information, Fig. S9.
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suppressed expression of N-myc in Huwe1-null cells to determine whether 
this manipulation would restore differentiation. Indeed, lentivirus-medi-
ated silencing of N-Myc rescued neuronal differentiation and expression 
of neuronal markers in Huwe1-knockout ES cells (Fig. 4e, f). Thus, the 
aberrant accumulation of N-Myc in the absence of Huwe1 is the crucial 
event that prevents neuronal differentiation of ES cells.
To extend our analysis of Huwe1-null ES cells to a conditional knock-
out system, we generated a floxed allele of murine Huwe1 with LoxP 
sites flanking exons 80 and 82, which encode the HECT domain. Cre-
mediated recombination of the only Huwe1flox allele in male Huwe1flox/y 
ES cells produced a Huwe1∆HECT allele, which lacks the HECT domain 
(Supplementary Information, Fig. S3). Cre-mediated inactivation of 
Huwe1 severely impaired the ability of ES cells to downregulate N-Myc 
following LIF withdrawal (Fig. 5a). Accordingly, N-Myc turnover was 
reduced more than 5-fold in Huwe1∆HECT ES cells grown in the absence 
of LIF, compared with Huwe1flox (N-Myc half-life in Huwe1flox: 15 min; 
Huwe1∆HECT: 86 min). Again, Huwe1 inactivation had a smaller effect 
on the stability of c-Myc (Fig. 5b, c). Consistent with the findings in ES 
cells carrying a trapped Huwe1 allele, conditional inactivation of Huwe1 
impaired induction of neuronal markers and prevented neuronal dif-
ferentiation under experimental conditions in which those effects were 
readily observed in Huwe1flox ES cells (Fig. 5d, e). Conversely, neuronal 
differentiation was unaffected in wild-type ES cells expressing the Cre 
recombinase, indicating that expression of Cre does not impair neuronal 
differentiation of ES cells (Supplementary Information, Fig. S4). We also 
examined whether elimination of N-Myc in Huwe1-expressing cells also 
operates in the nervous system in vivo. Immunohistochemistry for Huwe1 
and N-Myc in the mouse cortex at embryonic day 15.5 (E15.5) showed 
high levels of N-Myc in neural progenitors located in the germinal layers 
of the telencephalon but low levels of Huwe1. Conversely, N-Myc was 
absent in the differentiated neurons of the cortical plate. The expression 
of Huwe1 showed a marked increasing gradient as neuronal differentia-
tion proceeded such that the cortical plate contained the highest levels of 
Huwe1, compared with other mouse tissues at this stage of development 
(Fig. 5f; Supplementary Information, Fig. S5a and data not shown).
The Huwe1–N-Myc pathway controls proliferation and 
differentiation in the developing brain
To determine whether Huwe1 directs cell-cycle arrest and neuronal dif-
ferentiation in the developing brain by restraining the accumulation of 
N-Myc, we silenced Huwe1 and N-myc by ex vivo electroporation of 
the cortical germinal layers at mid-gestation, followed by organotypic 
slice culture44,45. Successfully electroporated cells were monitored by co-
expression of GFP. Electroporation of specific siRNA oligonucleotides 
efficiently silenced the expression of Huwe1 and N-myc, and knock-
down of Huwe1 elevated N-Myc (Supplementary Information, Fig. S5). 
To analyse proliferation, cortices from E14.5 mouse embryos were elec-
troporated with control siRNAs or siRNAs targeting N-myc, Huwe1 and 
N-myc–Huwe1 and then cultivated in the presence of BrdU. Consistent 
with the effects of N-myc knockout in the nervous system3, silencing of 
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N-myc caused a notable decrease in cycling cells, as measured by quan-
titative immunostaining for BrdU (Fig. 6a, b) and phospho-histone H3 
(pHH3, Fig. 6c; Supplementary Information, Fig. S6). Knockdown of 
Huwe1 produced the opposite effect, namely an increase in the fraction 
of proliferating cells, indicating that Huwe1 promotes cell-cycle exit of 
cortical progenitors. Consistent with the finding that Huwe1 operates as 
an upstream, negative regulator of N-Myc, concurrent silencing of Huwe1 
and N-myc abolished the phenotypic consequences of Huwe1 inactiva-
tion and led to a proliferation defect that was indistinguishable from 
that observed in N-myc-knockdown cortices (Fig. 6a–c; Supplementary 
Information, Fig. S6). Neither N-myc nor Huwe1 manipulation caused 
detectable changes in the fraction of apoptotic cells, as determined by 
quantitative immunostaining for caspase-3 and p53 (Supplementary 
Information, Fig. S7a–d). Targeted deletion of N-myc in neural stem 
cells leads to derepression of p27Kip1 and loss of the N-Myc target gene 
cyclin D2, two events considered crucial for the premature cell-cycle exit 
phenotype observed in N-myc-null brains3. To determine whether the 
Huwe1–N-Myc pathway also converges on p27Kip1 and cyclin D2, we 
monitored expression of p27Kip1 and cyclin D2 in cortices with silenced 
N-myc and Huwe1. As expected, p27Kip1 was elevated and cyclin D2 
decreased in N-myc knockdown cells, whereas p27Kip1 was decreased 
and cyclin D2 upregulated in Huwe1-silenced cortices. p27Kip1 remained 
elevated and cyclin D2 repressed in cells with combined silencing of 
N-myc and Huwe1 (Fig. 6d–f; Supplementary Information, Fig. S8).
Ectopic expression of p27Kip1 in the developing brain triggers prema-
ture differentiation by stabilizing Neurogenin2 (Ngn2) and consequent 
activation of neuronal differentiation markers44. Perturbation of the 
Huwe1–N-Myc pathway led to profound changes in the expression of 
Ngn2 and consequently in the differentiation status of the electropo-
rated cortices. Ngn2 is increased in the absence of N-Myc and the same 
effect was observed when N-myc and Huwe1 were concurrently silenced. 
However, the simple knockdown of Huwe1 was associated with marked 
depletion of Ngn2 from Huwe1-null cells (Fig. 7a, b). Finally, we analysed 
the expression of early (HuC/D, Fig. 7c) and late (TuJ1, Fig. 7e) markers 
of neuronal differentiation. HuC/D and TuJ1 were mostly absent in the 
control ventricular and subventricular areas, whereas they were readily 
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detected in the intermediate zone and cortical plate. However, a large frac-
tion of HuC/D- and TuJ1-positive cells were detected in the ventricular/
subventricular areas of N-myc-silenced cortices, a result which is consistent 
with the notion that N-Myc prevents premature differentiation of cortical 
progenitors. In contrast, Huwe1-null cortices showed a disproportionately 
reduced number of HuC/D- and TuJ1-positive cells, even in the inter-
mediate zone and cortical plate, indicating that loss of Huwe1 induces a 
differentiation defect. Again, concurrent knockdown of N-myc and Huwe1 
overcame the effects caused by Huwe1 depletion and led to a precocious 
differentiation phenotype that was identical to the isolated silencing of 
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N-myc (Fig. 7c–f). Therefore, we conclude that Huwe1 is essential for ini-
tiation of cell-cycle exit and differentiation in vivo and these events are 
mediated by the elimination of N-Myc from cortical progenitors.
DISCUSSION
In this study we examined the biological role of Huwe1, a HECT-
domain E3 ubiquitin ligase whose properties and function in vivo were 
unclear. We demonstrated the existence of a Huwe1–N-Myc pathway, 
in which Huwe1 operates on a linear pathway epistatic to N-Myc to 
allow neuronal differentiation and cell-cycle arrest of stem cells and 
cortical progenitors. We discovered that the phenotypic and molecu-
lar changes resulting from Huwe1 knockdown are fully reversed when 
expression of the N-myc gene is also silenced. Through experiments 
conducted in ES cells and neural progenitors in vivo, we showed that the 
mechanistic explanation for the above findings is the ability of Huwe1 
to bind to N-Myc and prime it for Lys 48-linked polyubiquitination and 
proteasomal-mediated degradation.
The Lys 48-mediated mechanism of ubiquitin linkage on N-Myc by 
Huwe1 and its recognition by the 26S proteasome for destruction is 
consistent with in vitro and in vivo observations in neuroblastoma cells, 
differentiating ES cells and developing brain where silencing of Huwe1 
expression invariably results in N-Myc accumulation and an extended 
half-life. Although a previous study found that c-Myc is also a substrate 
of Huwe1-mediated ubiquitination, it suggested that the polyubiquitin 
chains are mostly linked through Lys 63 and do not target degradation 
of c-Myc by the proteasome16. However, in this study, Huwe1 seemed to 
assemble different types of polyubiquitin chains (Lys 11, Lys 48, Lys 63). 
Here, we have conducted a detailed functional comparison of N-Myc and 
c-Myc as Huwe1 substrates. This analysis led to three conclusions. First, 
N-Myc and c-Myc are both ubiquitinated in vivo by Huwe1 through 
Lys 48-mediated linkages (Fig. 2d, e). Second, ubiquitination of N-Myc 
by Huwe1 is markedly more efficient than ubiquitination of c-Myc under 
identical experimental conditions (Fig. 2b). This effect is probably the 
consequence of a more efficient interaction of Huwe1 with N-Myc than 
with c-Myc (Fig. 1d). Third, constitutive and conditional genetic knock-
out of Huwe1 in ES cells results in the stabilization of endogenous N-Myc 
and c-Myc, albeit with markedly different rates (N-Myc stabilization is 
at least 3-fold more pronounced than c-Myc, Figs 3d–f, 5b, c).
The rather poor efficiency by which c-Myc binds, is ubiquitinated and 
degraded by Huwe1 may be one of the reasons for the failure to observe 
stabilization of c-Myc in cells where residual Huwe1 expression may still 
be present after RNA-interference-mediated silencing16. Furthermore, 
in the previous study, the ubiquitination assays were performed using 
a truncated version of Huwe1 that lacks the first 2472 amino acids16, 
whereas we have used full-length Huwe1 for all our experiments. Finally, 
the observation that Huwe1 assembles only Lys 48-mediated linkages on 
its substrates is consistent with that of a recent report in which a com-
bination of ubiquitin mutagenesis and mass spectrometry experiments 
revealed that HECT-domain E3 ligases can only form homogeneous 
ubiquitin chains (Lys 48 or Lys 63; ref. 24).
The most striking effect that emerged from inactivation of Huwe1 in 
ES cells and developing brain is the impaired differentiation along the 
neuronal lineage. We suggest that the activity of Huwe1 as negative regu-
lator of N-Myc provides a mechanistic explanation for this observation. 
Support for this idea comes from the sharp gradient of Huwe1 expression 
in the developing central nervous system, whereby Huwe1 is markedly 
upregulated as neuronal differentiation proceeds. Accordingly, the corti-
cal plate, which contains only post-mitotic and differentiated neurons 
that are invariably N-Myc-negative, is the area in the mouse embryo 
with the highest expression of Huwe1 at mid-gestation. Furthermore, the 
conclusion that Huwe1 operates on a linear pathway epistatic to N-Myc is 
firmly supported by the notion that concurrent silencing of Huwe1 and 
N-myc not only rescues the differentiation defect of Huwe1-null neurons 
but actually converts it into a premature cell-cycle exit/differentiation 
phenotype that is indistinguishable from that produced by single knock-
down of N-myc. As well as protecting post-mitotic neurons from re-
expression of N-Myc, thus preventing cell-cycle re-entry and loss of the 
differentiated state, the high levels of Huwe1 expression in the cortical 
plate may also be necessary to target other substrates possibly implicated 
in specialized neuronal activities. Consistent with this hypothesis is a 
recent screening in Caenorhabditis elegans, from which Huwe1 emerged 
as an essential gene for synaptogenesis46. However, Huwe1 substrates reg-
ulating synaptogenesis have not been found. Regardless of the full scope 
of Huwe1 substrates in differentiated neurons, our findings indicate that 
N-Myc is the crucial substrate in differentiating neural progenitors and 
identify the Huwe1–N-Myc pathway as a key modulator of differentia-
tion and quiescence in the neural tissue. 
METHODS
Cell culture. IMR32, SK-N-SH and U2OS cells were grown in DMEM contain-
ing 10% fetal bovine serum (FBS). U2OS cells stably expressing N-Myc were 
generated by transfecting cells with the retroviral vector pLZRS–IRES–GFP or 
pLZRS–IRES–GFP–N-Myc and selected in 2 µg ml–1 of puromycin. Cell trans-
fection was performed with Lipofectamine 2000 (Invitrogen). siRNAs were 
Huwe1 Smart Pool (Dharmacon). LaminA/C and firefly luciferase Smart Pools 
(Dharmacon) were used as negative controls. Retroviral infection was performed 
as described previously19. E14Tg2a-derived 46C ES cells (sox1–GFP knock-in ES 
cells) were a gift from Austin Smith37. RRE249 and HMA095 cells, also derived 
from E14Tg2a ES cells were obtained from BayGenomics. Undifferentiated mouse 
ES cells were maintained on gelatin-coated dishes in Glasgow minimal essential 
medium (GMEM, Sigma) supplemented with 10% FBS, 2 mM glutamine, 0.1 mM 
non-essential amino acids, 1 mM sodium pyruvate, 0.05 mM 2-mercaptoethanol 
(2-ME) and 1,000 U ml–1 of LIF (Chemicon). For neural differentiation, undif-
ferentiated ES cells were dissociated and plated onto poly-d-lysine- and laminin-
coated tissue culture plastic at a density of 3 × 104 cells/cm2 in N2B27 medium. 
The medium was replaced every 2 days. N2/B27 is a 1:1 mixture of DMEM-F12 
(Invitrogen) supplemented with modified N2 (25 µg ml–1 insulin, 100 µg ml–1 
apo-transferrin, 6 ng ml–1 progesterone, 16 µg ml–1 putrescine, 30 nM sodium 
selenite, 50 µg ml–1 bovine serum albumin fraction V and neurobasal medium 
supplemented with B27 (Invitrogen). Embryoid bodies were obtained by plating 
ES cells onto ultra-low-attachment 6-well plates (Invitrogen) at 2 × 105 cells ml–1 
in medium for ES cell culture without LIF. The medium was changed every other 
day. Retinoic acid (1 µM) was added from day 4 to day 8 (ref. 47).
For lentiviral transduction, Huwe1-trapped ES cells were seeded at a density of 
5 × 104 per well in 6-well plates and infected with control or lentivirus containing a 
short hairpin (sh) RNA sequence targeting N-myc (SHGLYC–TRCN0000020696, 
Sigma). Cells were treated according to the differentiation protocol described 
above, under adherent conditions 3 days after infection.
Biochemical methods. Extract preparation, immunoprecipitation and immu-
noblotting were performed as described previously13.
Ex vivo electroporation, cell counting and statistics. Ex vivo electroporation 
was performed as described previously44. Embryonic mouse heads were iso-
lated from E14.5 pregnant mice. Endotoxin-free GFP plasmid (1 µg µl–1), siRNA 
(10 µM, N-myc, Huwe1 and Control Smart Pool, Dharmacon) and fast green 
(Sigma) as an indicator were injected into lateral ventricles using a Femtojet 
microinjector (Eppendorf). The head was then electroporated using platinum 
electrodes (Nepagene) and an ECM 830 electroporator (BTX) with the following 
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parameters: 50 V, pulse duration 50 ms, pulse interval 1 s, and 5 pulses. 
Electroporated cerebral hemispheres were dissected and sectioned coronally into 
300-µm-thick slices using a vibratome (VT1000S, Leica). The slices were cul-
tured for 1.5 or 3 days in neurobasal medium containing 1% N2, 1% B27, 2 mM 
l-glutamine and penicillin–streptomycin/1% fungizone/5 µg ml–1 ciprofloxacine. 
For BrdU immunostaining, slices were labelled with 10 µM BrdU for 2 h before 
fixation. Slices were fixed in ice cold 4% paraformaldehyde at 4 °C for 2 h. After 
overnight incubation in PBS containing 20% sucrose, slices were embedded in 
OCT and kept at –80 °C. Cryostat sections were stained according to standard pro-
tocols using FITC and Cy3–conjugated secondary antibodies. In all experiments 
slices from two independent experiments were processed for each experimental 
condition. For each sample at least 3 adjacent sections were analysed by confocal 
microscopy and ×40 magnified fields zoomed ×1.5 were acquired. Experiments 
were repeated twice with similar results. Cells that were positive for GFP and 
Cy3 were scored. Results are presented as mean ± s.e.m. Statistical analysis was 
performed using unpaired two-tailed Student’s t-test between control and experi-
mental condition, or one-way ANOVA (ANOVA-1) followed by a Dunnett’s post 
hoc test for multiple comparisons (GraphPad Prism software, version 3.03).
RT–PCR. Total RNA was prepared with Trizol reagent (Invitrogen) and cDNA was 
synthesized using SuperScript II Reverse Transcriptase (Invitrogen). Quantitative 
real-time PCR (qRT–PCR) was performed using a 7500 sequence detection sys-
tem (Applied Biosystems) and iTaqTM SYBR green supermix (Bio-Rad). Primer 
sequences for mouse genes are available in the Supplementary Information. 
In vitro ubiquitination assay. Baculoviral expression and purification of full-length 
wild-type Huwe1 and Cys 4341 to Ala mutant Huwe1 (Huwe1–CA) were described 
previously14. Ubiquitination and degradation assays were performed as previously 
described13,48. Briefly, N-Myc and c-Myc ubiquitination was performed in a volume 
of 10 µl containing 2 µl of a 5× stock of a reaction mix (0.25 M Tris·HCl, pH 7.5, 
25 mM MgCl2, 10 mM ATP, 50 mM phosphocreatine and 17.5 U ml
–1 creatine phos-
phokinase, 0.1–2 µl of recombinant wild-type Huwe1 or 2 µl Huwe1–CA, 1.5 ng μl–1 
E1 (Boston Biochem), 10 ng μl–1 UbcH5, 2.5 μg μl–1 ubiquitin (Sigma), 1 μl 35S-me-
thionine-labelled in vitro transcribed/translated N-Myc and c-Myc as substrate. 
The reactions were incubated at 37 °C for 1 h or the indicated times and analysed 
by SDS–PAGE and autoradiography. Where indicated, wild-type ubiquitin was 
substituted with ubiquitin mutants (K48R, K63R or K48/63R). Degradation assays 
were performed in the presence or absence of 20 nM purified 26S proteasomes. 
After incubation at 37 °C for various times, reactions were stopped by the addition 
of sample buffer and subjected to SDS–PAGE followed by autoradiography.
In vivo ubiquitination assay. U2OS cells stably transfected with pLZRS–IRES–
GFP–N-Myc were cotransfected with pCDNA-V5 vector or pCDNA-V5–Huwe1 
plus wild-type pCMV–HA–Ubiquitin, pCMV–HA–Ubiquitin–Lys 48 only 
(K48O) or pCMV–HA–Ubiquitin–Lys 63 only (K63O). Thirty-six hours after 
transfection, cells were treated with 5 µm MG132 for 3 h and then lysed with 
radioimmunoprecipitation (RIPA) buffer containing 0.5% SDS, 0.5% sodium 
deoxycolate and 0.5% Nonidet P-40. Identical aliquots of cell lysates (2 mg) were 
used in immunoprecipitation assays with anti-N-Myc (Calbiochem) or anti-c-
Myc (Santa Cruz) monoclonal antibodies. Immunocomplexes were resolved on 
4–12% gradient gels and immunoblotting was performed using an anti-HA anti-
body (Roche). Total lysates (20 µg) were used for immunoblotting to evaluate the 
expression of V5-Huwe1 and HA–ubiquitins.
Generation of conditionally mutant Huwe1 ES cells. The Huwe1 conditional 
allele (Huwe1flox) was created by inserting an Frt-flanked pGKNeoR cassette into 
intron 82 and loxP sites into intron 79 and 82. Exons 80–82 encode most of the 
HECT domain of Huwe1. Cre-mediated recombination results in the removal 
of 197 amino acids. After homologous recombination in AB2.2 ES cells (gift 
from Allan Bradley, Wellcome Trust, Sanger Institute, Cambridge, UK), an 
expression vector of Cre recombinase was transiently transfected to delete the 
pGKNeoR cassette and exons 80–82 of Huwe1. The conditional floxed allele 
was genotyped using primers flanking the 5´ and 3´ loxP sites. The floxed allele 
produced a 4.6 kb genomic PCR product, the wild-type allele produced a 2.8 kb 
product and the floxed, recombined allele produced a 0.55 kb PCR product. 
RT–PCR using primers in exons 81 and 83 confirmed successful deletion of 
exons 80–82 in ES cells infected with Cre–IRES–GFP retrovirus but not in cells 
infected with GFP retrovirus.
Note: Supplementary Information is available on the Nature Cell Biology website.
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Figure S1 N-Myc binds Huwe1 in vivo. (a), Total extracts from SK-N-SH vector 
or stably expressing Flag-N-Myc were immunoprecipitated with Flag antibody. 
The levels of Huwe1 and N-Myc in the precipitates were determined by 
immunoblot. Input: 1/100 of total extracts used for each immunoprecipitation 
reaction.  (b), Lysates from IMR32 transfected with plasmids expressing 
the V5-tagged N-terminus (1-1041), C-terminus (1041-4034) of Huwe1 
or the empty vector. Endogenous levels of N-Myc and p53 were analyzed 
by immunoblot. The V5 antibody was used to detect exogenously expressed 
Huwe1. (c), Expression and purification of full-length Huwe1 from 
baculoviruses. Recombinant Huwe1 wild type and the catalytically inactive 
mutant Huwe1-CA were analyzed by SDS-PAGE and Coomassie staining. 
Recombinant proteins were used in ubiquitination and degradation assays. 
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Figure S2 Structure and analysis of Huwe1 trapped ES cell clones. (a), Trap 
vector is inserted into intron 4 and intron 74 in clone RRE249  and clone 
HMA095, respectively. (b), Trap vector insertion was confirmed by PCR using 
primer pair a for clone RRE249 (red triangles, product size: 3.1 Kb) and 
primer pair b for clone HMA095 (blue triangles; product size: 2.3Kb).Wild 
type ES cells are used as control. (c), Immunoblot using Huwe1 antibody 
from wild type, RRE249 and HMA095 ES cells demonstrates the absence of 
Huwe1 protein in clone RRE249. Asterisk indicates a non-specific band.
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Figure S3 Generation of ES cells carrying a conditional mutant allele of 
Huwe1 by gene targeting. (a), Structure of the Huwe1 genomic locus, 
targeting vector and targeted locus. The pGKNeoR cassette is in the 
opposite transcriptional orientation to the Huwe1 gene. Upon Cre-mediated 
recombination the region between exons 80 and 82 is deleted. Primer 
pairs used for PCR are indicated. (b), Targeted cells were transfected with 
vector (lane 1) or plasmid encoding Cre recombinase (lane 2). Genomic 
PCR with primers a and b demonstrates that LoxP sites in targeted ES 
cells are functional. (c), RT-PCR analysis of Huwe1 mRNA in homologous 
recombined ES cells after infection with retroviruses expressing GFP (lane 
1) or Cre recombinase (lane 2) using primer c and d (exon 81 and exon 83 
respectively).
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Figure S4 Expression of Cre recombinase in ES cells does not affect 
neuronal differentiation. Embryoid bodies derived from wild type and 
Huwe1Flox ES cells that had been transduced with a Cre expressing 
retrovirus were allowed to adhere after being cultured in suspension for 8 
days. Bright-field images were taken 2 and 4 days after re-plating. Scale bar 
is 150 µm.
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Figure S5 Expression of N-Myc protein is increased in neural progenitors 
following Huwe1 loss. (a), Control and Huwe1 siRNA were electroporated ex vivo 
into E13.5 mouse cortices. Organotypic slice culture was performed for 3 days. 
Cortical slices were double labeled with Huwe1 (red) and GFP (green) to identify 
transfected cells. Scale bars are 50 µm. b, Quantification of GFP-positive/
Huwe1-positive cells. (c), Cortical slices were double labeled with N-Myc (red) 
and GFP (green). (d), Quantification of GFP-positive/N-Myc-positive cells.  
(e) Control, N-myc, Huwe1, and N-myc plus Huwe1 siRNA were electroporated 
into E13.5 mouse cortices followed by organotypic slice culture for 1.5 days. 
Cortical slices were double labeled with N-Myc (red) and GFP (green). Scale bars 
are 50 µm. (f), Quantification of GFP-positive/N-Myc-positive cells. Results are 
mean±SEM (n = 3 from two independent experiments ;*, P < 0.05 **, P < 0.01 
Student’s t-test). Arrowheads indicate GFP-positive/Cy3-positive cells; arrows 
indicate GFP-positive/Cy3-negative cells.
© 2008 Nature Publishing Group 
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Figure S6 Analysis of mitotic activity in embryonic cortices following 
silencing of Huwe1 and N-myc. Ex vivo electroporation of Control, 
N-myc, Huwe1, and N-myc plus Huwe1 siRNA into E13.5 mouse 
cortices followed by organotypic slice culture for 1.5 days. Cortical 
slices were double labeled with pHH3 (red) and GFP (green) to identify 
transfected cells. Arrowheads indicate GFP-positive/Cy3-positive cells; 
arrows indicate GFP-positive/Cy3-negative cells. Scale bars are  
50 µm.
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Figure S7 Silencing of Huwe1 in neural progenitors does not affect p53 
expression or apoptotic cell death. (a), Ex vivo electroporation of Control, 
N-myc, Huwe1, and N-myc plus Huwe1 siRNA into E13.5 mouse cortices 
followed by organotypic slice culture for 1.5 days. Cortical slices were double 
labeled with p53 (red) and GFP (green) to identify transfected cells. (b), 
Quantification of GFP-positive/p53-positive cells. (c), Cortical slices were 
double labeled with Caspase-3 (red) and GFP (green). (d), Quantification of 
GFP-positive/Caspase-3-positive cells. Arrowheads indicate GFP-positive/
Cy3-positive cells; arrows indicate GFP-positive/Cy3-negative cells. Results are 
mean±SEM (n = 3 from two independent experiments). Scale bars are 50 µm.
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Figure S8 Analysis of expression of cyclin D2 in embryonic cortices 
following silencing of Huwe1 and N-myc. Ex vivo electroporation of 
Control, N-myc, Huwe1, and N-myc plus Huwe1 siRNA into E13.5 
mouse cortices followed by organotypic slice culture for 1.5 days. 
Cortical slices were double labeled with Cyclin D2 (red) and GFP (green) 
to identify transfected cells. Arrowheads indicate GFP-positive/Cy3-
positive cells; arrows indicate GFP-positive/Cy3-negative cells. Scale 
bars are 50 µm.
© 2008 Nature Publishing Group 
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Figure S9 Full scans of key western blot data shown in Figure 1b-d, f, 
h; Figure 2d; Figure 3a, d; Figure 4a, d-e; Figure 5a-b. The molecular 
weight is indicated at the right-hand side. Arrows indicate the analyzed 
protein.
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